PRESS RELEASE published on 07/29/2024 at 07:30, 1 year 4 months ago DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point sur l’évolution de ses activités DBV Technologies annonce ses résultats financiers du premier semestre 2024 et une conférence le jeudi 30 juillet 2024. L'entreprise se spécialise dans le traitement des allergies alimentaires Résultats Financiers Biopharmaceutique Conférence Téléphonique DBV Technologies Allergies Alimentaires
BRIEF published on 07/08/2024 at 22:35, 1 year 4 months ago Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF Contrat De Liquidité Bilan Semestriel ODDO BHF Transactions Boursières DBV Technologies
BRIEF published on 07/08/2024 at 22:35, 1 year 4 months ago Half-yearly review of the DBV Technologies liquidity contract with ODDO BHF Liquidity Contract ODDO BHF Stock Transactions DBV Technologies Half-yearly Review
PRESS RELEASE published on 07/08/2024 at 22:30, 1 year 4 months ago Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies publie le bilan semestriel de son contrat de liquidité avec ODDO BHF, incluant les moyens en actions et en euros, ainsi que les transactions effectuées Contrat De Liquidité Bilan Semestriel Transactions ODDO BHF DBV Technologies
PRESS RELEASE published on 07/08/2024 at 22:30, 1 year 4 months ago Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies issues Half-Year Report on Liquidity Contract with ODDO BHF, revealing assets and transaction details for the period Liquidity Contract Transactions Half-year Report ODDO BHF DBV Technologies
BRIEF published on 06/05/2024 at 22:35, 1 year 5 months ago DBV Technologies to Participate in Goldman Sachs 45th Annual Global Healthcare Conference Investors DBV Technologies Viaskin Goldman Sachs Global Healthcare Conference Daniel Tassé
BRIEF published on 06/05/2024 at 22:35, 1 year 5 months ago DBV Technologies participera à la 45e conférence annuelle mondiale sur les soins de santé de Goldman Sachs Investisseurs DBV Technologies Viaskin Daniel Tassé Conférence Mondiale Sur La Santé De Goldman Sachs
PRESS RELEASE published on 06/05/2024 at 22:30, 1 year 5 months ago DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference DBV Technologies to participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10th, featuring CEO Daniel Tassé in a fireside chat and investor meetings. Live webcast available online Biopharmaceutical DBV Technologies Food Allergies Goldman Sachs Global Healthcare Conference Daniel Tassé
PRESS RELEASE published on 06/05/2024 at 22:30, 1 year 5 months ago DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare avec Daniel Tassé présentant. Focus sur traitement allergies alimentaires et nouvelles immunothérapies DBV Technologies Allergies Alimentaires Viaskin Goldman Sachs Global Healthcare Immunothérapies
BRIEF published on 06/04/2024 at 22:35, 1 year 6 months ago DBV Technologies Reports Voting Rights and Shares Information as of May 31, 2024 Voting Rights Shares AMF Regulations DBV Technologies
Published on 12/05/2025 at 20:25, 10 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 20 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 45 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 15 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 50 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 1 hour 37 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 19 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 2 hours 48 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 17 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 17 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 24 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 24 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 36 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE